TY - JOUR AU - Tatebe, Harutsugu AU - Kasai, Takashi AU - Ohmichi, Takuma AU - Kishi, Yusuke AU - Kakeya, Tomoshi AU - Waragai, Masaaki AU - Kondo, Masaki AU - Allsop, David AU - Tokuda, Takahiko PY - 2017 DA - 2017/09/04 TI - Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome JO - Molecular Neurodegeneration SP - 63 VL - 12 IS - 1 AB - There is still a substantial unmet need for less invasive and lower-cost blood-based biomarkers to detect brain Alzheimer’s disease (AD) pathology. This study is aimed to determine whether quantification of plasma tau phosphorylated at threonine 181 (p-tau181) is informative in the diagnosis of AD. SN - 1750-1326 UR - https://doi.org/10.1186/s13024-017-0206-8 DO - 10.1186/s13024-017-0206-8 ID - Tatebe2017 ER -